Best Pharma Healthcare Funds — Ranked by Returns & Risk

Pharma & healthcare funds back drugmakers, hospitals and diagnostics. A relatively defensive theme with steady long-term demand, less tied to the broader market's swings — though still a single-sector bet.

How these funds are ranked

We rank Direct Plan, Growth-option schemes by their long-term trailing returns (5-year, falling back to 3-year then 1-year) using live NAV data. Direct plans carry a lower expense ratio than regular plans, so they deliver higher returns for the same fund over time. Rankings are for information only — not investment advice.

Frequently asked questions

Are direct plans better than regular plans?

Direct plans have no distributor commission, so their expense ratio is lower and their returns are higher for the same underlying fund. That is why we rank direct plans here.

Do past returns guarantee future performance?

No. Past performance does not guarantee future results. Use these rankings as a starting point, then check each fund’s risk, expense ratio, consistency and how long it has existed before investing. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.